Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 5, 2018

View Archived Issues

Germline variants, tumor variation

Monalizumab's mysteries

Placenta organoids to give insights into pregnancy's mysteries

Advanced Accelerator Applications and Fujifilm Toyama sign license agreement for FF-10158 for cancer

Novo Nordisk initiates phase II study of once-weekly insulin 287 in type 2 diabetes

Oryzon initiates phase IIa study of iadademstat in second-line SCLC

Calygene Biotechnology patents new ML1 antagonists

University of Pennsylvania divulges anti-PF-4 antibodies

aTyr Pharma initiates phase Ib/IIa study of ATYR-1923 in patients with pulmonary sarcoidosis

University of Louisville stem cell-derived exosomes for cancer

ALLO-715 CAR T cells exhibit antitumor potency in in vitro and in vivo models of R/R MM

New PROTAC DT-2216 shows promising preclinical activity against BCL-X(L)-dependent tumors

Novel degraders of IRAK-4 demonstrate promising preclinical activity in ABC-DLBCL models

GRB10 identified as a novel therapeutic target in AML

DCB-HDG2-411 shows promising preclinical activity for Hh pathway-driven cancers

GPA-500 reduces tumor growth in models of enzalutamide-resistant prostate cancer

Exelixis and Ipsen initiate COSMIC-312 phase III study of cabozantinib plus atezolizumab in HCC

Aridis announces new milestones in AR-501 development

Faron identifies optimal subgroup of patients for Traumakine treatment in INTEREST study

First patient dosed in phase II study of MEDI-0457 plus durvalumab in HPV-associated cancers

Carnot Biosciences and HemoShear Therapeutics to develop protein-based therapeutics

PersImmune presents first-in-human data for PACTN in MDS

FLT180a gene therapy safe in first two hemophilia B patients in clinical trial

Hookipa Biotech initiates phase II study of HB-101 in kidney transplant patients

ImmuneMed initiates phase I study of hzVSF-v13

Cytokinetics begins clinical testing of CK-3773274

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...